<DOC>
	<DOCNO>NCT01506076</DOCNO>
	<brief_summary>The purpose study assess Bioequivalence Levocetirizine DiHCl Tablets 5mg XYZAL tablet 5 mg monitor clinical status , adverse event laboratory investigation assess relative safety tolerance , fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Levocetirizine DiHCl Tablets 5mg Dr. Reddy 's Under Fasting Conditions</brief_title>
	<detailed_description>A pivotal study compare Bioequivalence Levocetirizine DiHCl Tablets 5 mg Dr.Reddy 's Laboratories Limited XYZAL® Tablets 5 mg UCB Farchim S.A. healthy , human subject fast condition .</detailed_description>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Subjects provide write informed consent . Subjects must healthy adult within 1845 year age ( inclusive ) . Body mass index ≥18.5 kg/m2 ≤25 kg/m2 , body weight less 50 kg . Subjects must normal health determine medical history physical examination perform within 15 day prior commencement dose PeriodI . Have normal ECG , chest XRay vital sign clinically non significant change ECG &amp; chest XRay . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . Subjects Non smoker moderate smoker ( less 10 cigarette day ) least 6 month . If subject female volunteer child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) •Each female subject give urine pregnancy test screening , checkin period1 , period2 post study . Subjects incapable understanding informed consent . Subjects BP lesser 90/60 mm Hg BP great equal 140/90 mm Hg . History hypersensitivity idiosyncratic reaction Levocetirizine relate drug . Any evidence impairment renal , hepatic , gastro intestinal , lung cardiac function . Subjects history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Regular smoker smoke ten cigarette daily difficulty abstain smoke duration study period . Subjects take counter prescribed medication , include enzyme modifying drug systemic medication within past two week prior prior dose Period1 . History psychiatric illness , may impair ability provide write , informed consent . Subject mentally legally incapacitate , history significant psychiatric disorder . Subjects history alcohol substance/ drug abuse within last 5 year . Subjects clinically significant abnormal value laboratory parameter , include positive result HIV , HBV , HCV , RPR test . Subjects participate clinical investigation use experimental drug bleed 350 mL past 3 month . Subjects unable likely noncompliant protocol requirement restriction . Subjects intolerant venipuncture . Any subject Levocetirizine Dihydrochloride contraindicate medical reason . Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive within 14 day dose . Female volunteer demonstrate positive pregnancy screen . All female subject screen pregnancy screening , checkin study period . Subjects positive inconclusive result withdrawn study . Female volunteer currently breast feed . Female subject pregnant , breastfeed likely become pregnant study allow participate . Female subject child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . Subjects positive urine screen drug abuse time admission checkin period exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>